research use only
Cat.No.S0193
| Related Targets | CXCR Hedgehog/Smoothened PKA Adrenergic Receptor AChR 5-HT Receptor Histamine Receptor Dopamine Receptor Ras KRas |
|---|---|
| Other GPCR19 Inhibitors | SBI-115 INT-777 SB-756050 BAR501 |
| Molecular Weight | 361.22 | Formula | C18H14Cl2N2O2 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 1197300-24-5 | -- | Storage of Stock Solutions |
|
|
| Synonyms | TGR5, CCDC, MDK00245 | Smiles | CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N(C)C3=CC=C(C=C3)Cl | ||
|
In vitro |
DMSO
: 96 mg/mL
(265.76 mM)
Ethanol : 12 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
GPCR19
(in melanophore cells assay) 7.5(pEC50)
GPCR19
(in U2-OS cell assay) 6.8(pEC50)
|
|---|---|
| In vitro |
This compound (TGR5, CCDC, MDK00245, compd 6) shows improved potency in the U2-OS cell assay (pEC50=6.8) and in melanophore cells (pEC50=7.5). |
| In vivo |
TGR5 Receptor Agonist (TGR5, CCDC, MDK00245, compd 6), a highly selective small molecule, shows significant improvements in hepatic portal vein GLP-1 secretion and reduction in portal vein glucose levels. |
References |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04959864 | Recruiting | Male Infertility |
GYNOV|Laboratoire Drouot |
July 7 2021 | Not Applicable |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.